» Articles » PMID: 16632633

Update in Cystic Fibrosis 2005

Overview
Specialty Critical Care
Date 2006 Apr 25
PMID 16632633
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells.

Scialo F, Cernera G, Polise L, Castaldo G, Amato F, Villella V Int J Mol Sci. 2024; 25(19).

PMID: 39408688 PMC: 11476568. DOI: 10.3390/ijms251910360.


Advanced lung organoids for respiratory system and pulmonary disease modeling.

Joo H, Min S, Cho S J Tissue Eng. 2024; 15:20417314241232502.

PMID: 38406820 PMC: 10894554. DOI: 10.1177/20417314241232502.


Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.

Vali P, Shahcheraghi F, Seyfipour M, Zamani M, Allahyar M, Feizabadi M J Clin Diagn Res. 2014; 8(1):26-30.

PMID: 24596716 PMC: 3939568. DOI: 10.7860/JCDR/2014/6877.3916.


Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator.

Villella V, Esposito S, Bruscia E, Vicinanza M, Cenci S, Guido S Cell Death Differ. 2013; 20(8):1101-15.

PMID: 23686137 PMC: 3705602. DOI: 10.1038/cdd.2013.46.


Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.

Luciani A, Villella V, Esposito S, Gavina M, Russo I, Silano M Autophagy. 2012; 8(11):1657-72.

PMID: 22874563 PMC: 3494594. DOI: 10.4161/auto.21483.


References
1.
Lewis H, Zhao X, Wang C, Sauder J, Rooney I, Noland B . Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem. 2004; 280(2):1346-53. DOI: 10.1074/jbc.M410968200. View

2.
Baker S, Borowitz D, Duffy L, FitzPatrick L, Gyamfi J, Baker R . Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis. J Pediatr. 2005; 146(2):189-93. DOI: 10.1016/j.jpeds.2004.09.003. View

3.
Voynow J, Fischer B, Roberts B, Proia A . Basal-like cells constitute the proliferating cell population in cystic fibrosis airways. Am J Respir Crit Care Med. 2005; 172(8):1013-8. DOI: 10.1164/rccm.200410-1398OC. View

4.
Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F . Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med. 2005; 172(12):1523-8. DOI: 10.1164/rccm.200502-253OC. View

5.
Sloane A, Lindner R, Prasad S, Sebastian L, Pedersen S, Robinson M . Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am J Respir Crit Care Med. 2005; 172(11):1416-26. DOI: 10.1164/rccm.200409-1215OC. View